ENT Stock Overview
Engages in the exploration of mineral properties in Australia. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Enterprise Metals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.003 |
52 Week High | AU$0.005 |
52 Week Low | AU$0.002 |
Beta | 1.23 |
11 Month Change | -25.00% |
3 Month Change | 0% |
1 Year Change | 0% |
33 Year Change | -76.92% |
5 Year Change | -66.67% |
Change since IPO | -98.50% |
Recent News & Updates
Recent updates
Shareholder Returns
ENT | AU Metals and Mining | AU Market | |
---|---|---|---|
7D | -25.0% | 1.6% | 0.9% |
1Y | 0% | -10.8% | 18.4% |
Return vs Industry: ENT exceeded the Australian Metals and Mining industry which returned -11.3% over the past year.
Return vs Market: ENT underperformed the Australian Market which returned 17.7% over the past year.
Price Volatility
ENT volatility | |
---|---|
ENT Average Weekly Movement | n/a |
Metals and Mining Industry Average Movement | 10.9% |
Market Average Movement | 8.6% |
10% most volatile stocks in AU Market | 17.3% |
10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine ENT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | n/a | n/a | www.enterprisemetals.com.au |
Enterprise Metals Limited engages in the exploration of mineral properties in Australia. It primarily explores for copper, gold, nickel, zinc, iron ore, titanium, heavy minerals, lithium, rare earths, and base metals. The company was formerly known as Revere Mining Limited and changed its name to Enterprise Metals Limited in December 2008.
Enterprise Metals Limited Fundamentals Summary
ENT fundamental statistics | |
---|---|
Market cap | AU$3.31m |
Earnings (TTM) | -AU$1.17m |
Revenue (TTM) | AU$65.18k |
50.8x
P/S Ratio-2.8x
P/E RatioIs ENT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ENT income statement (TTM) | |
---|---|
Revenue | AU$65.18k |
Cost of Revenue | AU$0 |
Gross Profit | AU$65.18k |
Other Expenses | AU$1.24m |
Earnings | -AU$1.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0011 |
Gross Margin | 100.00% |
Net Profit Margin | -1,795.53% |
Debt/Equity Ratio | 0% |
How did ENT perform over the long term?
See historical performance and comparison